Show
Sort by
-
European Groundshot addressing Europe's cancer research challenges : a Lancet Oncology Commission
-
Definition of synchronous oligometastatic non–small cell lung cancer : a consensus report
-
Moonshot or groundshot : addressing Europe's cancer challenge through a patient-focused, data-enabled lens
-
Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)
-
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)